GL1X · GenesisL1 explorer

MolNFT v1 · #123493 · protein

Receptor binding domain of botulinum neurotoxin a in complex with human glycosylated SV2C

5JLV · Botulinum neurotoxin type a: “Receptor binding domain of botulinum neurotoxin a in complex with human glycosylated SV2C”. X-ray diffraction, 4 ligands (NAG, FUC, BMA), 11 pockets (best druggability 0.56). MolNFT v1 #123493 on…

PDB
5JLV
Type
protein
Length
1,038 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a; Synaptic vesicle glycoprotein 2C
EC
3.4.24.69
UniProt
P10845, Q496J9
Ligands
NAG, FUC, BMA, PO4
Pockets
11 · best druggability 0.56

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBotulinum neurotoxin type a (EC 3.4.24.69)protein4258% helix, 46% strandP10845
CSynaptic vesicle glycoprotein 2Cprotein973% helix, 62% strandQ496J9
DSynaptic vesicle glycoprotein 2Cprotein913% helix, 67% strandQ496J9

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains A, C, B, D
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A, C, B, D
  • BMA · beta-D-mannopyranose · sugar · chains A
  • PO4 · Phosphate ion · ion · 3 copies · chains A, B
  • ACT · Acetate ion · additive · 3 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11770.560.8022empty
21660.520.7929ACT
31210.500.8026empty
41860.460.7526empty
51520.430.7521empty

Interfaces

4 interfaces between chains.

  • A–C · 621 Ų buried · 14 hydrogen bonds · protein-protein
  • B–D · 617 Ų buried · 13 hydrogen bonds · protein-protein
  • B–C · 472 Ų buried · 2 hydrogen bonds · protein-protein
  • A–D · 16 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 glycan (N-glycosylation).

Compared structures

  • 5JLV · Receptor binding domain of Botulinum neurotoxin A in complex with human glycosylated SV2C · the same entry in another collection · chain A against A, TM-score 1.00
  • Q496J9 · AlphaFold monomer V2.0 prediction for synaptic vesicle glycoprotein 2C (Q496J9) · a predicted model of the same protein · chain D against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.